Robert Z. Orlowski, MD from MD Anderson Cancer Center discusses further research in Multiple Myeloma and adapting to a minimal residual disease driven approach at the 2017 American Society of Hematology.
Further research in Multiple Myeloma – Adapting to a minimal residual disease driven approach
